A Phase II, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial Evaluating the Role of an Empiric 2-Week Course of Ciprofloxacin on Rates of Detection of Cancer by Prostate Biopsy in Men With Abnormal Serum Prostate Specific Antigen Found at Screening (PREP Trial)
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2018
Price : $35 *
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PREP
- 31 Aug 2018 Biomarkers information updated
- 28 Jul 2017 Planned End Date changed from 1 Jul 2016 to 31 Jul 2016.
- 28 Jul 2017 Planned primary completion date changed from 1 Dec 2018 to 31 Jul 2016.